Back to companies

Momenta Pharmaceuticals Inc: Patents

Select Item

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $125 per month (billed Annually)
Signup to View Free Sample

View up-to-date information on Momenta Pharmaceuticals Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US11352415B2 Grant Methods for the treatment of neurodegeneration A61K2039/505; A61K2039/54; A61K2039/545; C07K16/00; C07K16/06; C07K2317/41; G01N2333/52; G01N2500/10; G01N33/6896 June 07, 2022
US11345751B2 Grant FcRn antibodies and methods of use thereof A61P37/02; C07K16/28; C07K2317/565 May 31, 2022
WO2022109327A1 Application SIALYLATED GLYCOPROTEINS C07K9/001; G01N2400/00; G01N2458/15; G01N33/6848; G01N33/6857 May 27, 2022
US20220153833A1 Application METHODS RELATED TO ENGINEERED Fc CONSTRUCTS C07K16/283; C07K2317/35; C07K2317/52 May 19, 2022
IL291465D0 Application Compositions and methods related to engineered fc-antigen binding domain constructs targeted to cd38 A61K2039/505; A61P35/02; C07K16/2896; C07K2317/52; C07K2317/64; C07K2317/72; C07K2317/732; C07K2317/734 May 01, 2022
Discover Company Analytics for more exclusive patent trend analysis Discover Company Analytics for more exclusive patent trend analysis Get Started

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you subscribe Identify the top inventors associated with your target company when you subscribe Learn More
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer